| Urinary System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 236show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 215 trials (111 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 215 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 192 trials (62 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 192 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 167 trials (73 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 167 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 146 trials (10 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 146 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 132 trials (44 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 132 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 79 trials (45 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 77 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 77 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 71 trials (41 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 67 trials (22 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 67 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 66 trials (22 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 61 trials (13 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 61 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 59 trials (12 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 59 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 58 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 48 trials (13 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 47 trials (22 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 46 trials (16 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 46 trials (8 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 46 trials (39 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 43 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 42 trials (18 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 34 trials (17 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 30 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 29 trials (13 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 29 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 27 trials (22 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 24 trials (19 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 23 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 19 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 12 trials (11 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valrubicinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisotumab Vedotinadc 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 5-Aminolevulinic Acid 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Catumaxomabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alpha-2a 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rogaratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 5-Fluoro-2-Deoxycytidine 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD-1 Monoclonal Antibody MEDI0680 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumab/Tremelimumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Estramustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Histaminesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibuprofensmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Neoplasm | 1 | Observed | clinicaltrials | graph → |